Bjarke M Klein
Overview
Explore the profile of Bjarke M Klein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
698
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nelson S, Fauser B, Garcia-Velasco J, Klein B, Arce J
Fertil Steril
. 2024 Jan;
121(4):707.
PMID: 38266801
No abstract available.
2.
Visnova H, Papaleo E, Martin F, Koziol K, Klein B, Mannaerts B
Reprod Biomed Online
. 2021 Nov;
43(6):1019-1026.
PMID: 34756645
Research Question: How does the efficacy and safety of individualized follitropin delta dosing compare with conventional dosing for ovarian stimulation in potential high responders? Design: Retrospective analysis of 153 potential...
3.
Ishihara O, Klein B, Arce J
Fertil Steril
. 2020 Dec;
115(6):1478-1486.
PMID: 33272623
Objective: To establish the relationship between follitropin delta doses (recombinant follicle-stimulating hormone produced from the human cell line PER.C6) and ovarian response in Japanese women undergoing in vitro fertilization/intracytoplasmic sperm...
4.
Nyboe Andersen A, Nelson S, Fauser B, Garcia-Velasco J, Klein B, Arce J
Fertil Steril
. 2016 Dec;
107(2):387-396.e4.
PMID: 27912901
Objective: To compare the efficacy and safety of follitropin delta, a new human recombinant FSH with individualized dosing based on serum antimüllerian hormone (AMH) and body weight, with conventional follitropin...
5.
Bosch E, Nyboe Andersen A, Barri P, Garcia-Velasco J, De Sutter P, Fernandez-Sanchez M, et al.
Clin Endocrinol (Oxf)
. 2015 Jul;
83(6):902-12.
PMID: 26202150
Objective: To study the association between serum anti-Müllerian hormone (AMH) levels and follicular development and endocrine responses induced by increasing doses (5·2-12·1 μg/day) of a novel recombinant human FSH (rhFSH,...
6.
Nelson S, Klein B, Arce J
Fertil Steril
. 2015 Jan;
103(4):923-930.e1.
PMID: 25624196
Objective: To compare antimüllerian hormone (AMH) and antral follicle count (AFC) as predictors of ovarian response to controlled ovarian stimulation at individual fertility clinics. Design: Retrospective analysis of individual study...
7.
Arce J, Nyboe Andersen A, Fernandez-Sanchez M, Visnova H, Bosch E, Garcia-Velasco J, et al.
Fertil Steril
. 2014 Sep;
102(6):1633-40.e5.
PMID: 25256937
Objective: To evaluate the dose-response relationship of a novel recombinant human FSH (rhFSH; FE 999049) with respect to ovarian response in patients undergoing IVF/intracytoplasmic sperm injection treatment; and prospectively study...
8.
Arce J, Klein B, La Marca A
Gynecol Endocrinol
. 2014 Mar;
30(6):444-50.
PMID: 24576226
The aim was to compare ovarian response and clinical outcome of potential high-responders after stimulation with highly purified menotropin (HP-hMG) or recombinant follicle-stimulating hormone (rFSH) for in vitro fertilisation/intracytoplasmic sperm...
9.
Juul K, Klein B, Norgaard J
Neurourol Urodyn
. 2012 Sep;
32(4):363-70.
PMID: 22972524
Aims: To explore the durability of efficacy and gender differences during chronic administration of desmopressin in nocturia. Methods: This pooled analysis of three short-term efficacy studies, with extensions, of desmopressin...
10.
Anckaert E, Smitz J, Schiettecatte J, Klein B, Arce J
Hum Reprod
. 2012 Apr;
27(6):1829-39.
PMID: 22473395
Background: This study evaluated the predictive value of serum and follicular fluid (FF) concentrations of anti-Müllerian hormone (AMH) with respect to treatment outcome variables in an IVF cycle. Methods: A...